Antibacterial therapy of acute medium otitis under in outpatient conditions


DOI: https://dx.doi.org/10.18565/therapy.2019.8.167-172

Goncharova S.A.

No. 6 outpatient Department of Belgorod City polyclinic
Article discusses the choice of affordable antibiotic therapy used in the treatment of patients with acute otitis media in outpatient conditions. A comparative analysis of the clinical effectiveness of the most commonly used groups of antibacterial remedies, such as third-generation cephalosporins, macrolides, and protected penicillins, taking into account their antibacterial effectiveness and the duration of antibacterial treatment, which are the fundamental factors in choosing adequate antibiotic therapy for acute otitis media in an outpatient setting, was carried out.
Keywords: acute otitis media, antibacterial therapy of acute otitis media, cefixime (Pancef®), macrolides, protected penicillins
Read entire article

Literature


  1. Белов Б.С. Цефиксим в терапии бактериальных инфекций, вопросы эффективности и безопасности. РМЖ. 2013; 3: 147.

  2. Карнеева О.В. , Поляков Д.П., Гуров А.В. с соавт. Отит средний острый. Клинические рекомендации КР 314. Минздрав РФ. 2016.

  3. Крюков А.И. Туровский А.В. Острый средний отит, основные принципы лечения в современных условиях . Consilium Medicum. 2002: 2(5); 11–17.

  4. Пальчун В.Т. , Крюков А.И., Кунельская Н.Л. и др. Острое воспаление среднего уха. Вестник оториноларингологии. 1997; 6: 7–11.

  5. Тец В.В., Тец Г.В. Инфекции в оториноларингологии. Клинические рекомендации. 2013.

  6. Harrison C.Y., Chartrand S.A., Picichero M.E. Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children. Pediatr Infect Dis J. 1993; 12: 62–69.

  7. Leggett N.J., Caravaggio C., Rybak M.J. Cefixime. DICP Ann Pharmacother. 1990; 24: 489–95.

  8. Кузьменков А.Ю., Трушин И.В., Авраменко А.А., Эйдельштейн М.В., Дехнич А.В., Козлов Р.С. AMRmap: интернет-платформа мониторинга антибиотикорезистентности. Клиническая микробиология и антимикробная химиотерапия. 2017; 19(2): 84–90.

  9. Dagan R., Leibovitz E. Bacterial eradication in the treatment of otitis media Lancet Infect Dis. 2002; 2(10): 593–604.

  10. Dagan R., Leibovitz E. Achieving bacterial eradication using pharmacokinetics pharmacodynamics principles Int J Infect Dis. 2003; 7: S21–S26.

  11. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together [05-12-2016]. Информация доступна на сайте: http://www.fda.gov/Drugs/DrugSafety/ucm500143.htm


About the Autors

Svetlana A. Goncharova, otorhinolaryngologist of No.6 outpatient Department of Belgorod City polyclinic. Address: 308600, Belgorod, 99 Belgorodsky Prospect. Tel.: +7 (4722) 55-22-02. E-mail: poliklinika.belgorod@mail.ru

Back to Content

Бионика Медиа